BMRA
Price
$3.32
Change
-$0.11 (-3.21%)
Updated
Jun 12 closing price
Capitalization
14M
SYK
Price
$380.49
Change
-$0.59 (-0.15%)
Updated
Jun 12 closing price
Capitalization
134.94B
48 days until earnings call
Interact to see
Advertisement

BMRA vs SYK

Header iconBMRA vs SYK Comparison
Open Charts BMRA vs SYKBanner chart's image
Biomerica
Price$3.32
Change-$0.11 (-3.21%)
Volume$8.75K
Capitalization14M
Stryker
Price$380.49
Change-$0.59 (-0.15%)
Volume$877.93K
Capitalization134.94B
BMRA vs SYK Comparison Chart
Loading...
BMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRA vs. SYK commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRA is a Buy and SYK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2025
Stock price -- (BMRA: $3.32 vs. SYK: $380.49)
Brand notoriety: BMRA and SYK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BMRA: 11% vs. SYK: 64%
Market capitalization -- BMRA: $14M vs. SYK: $134.94B
BMRA [@Medical Specialties] is valued at $14M. SYK’s [@Medical Specialties] market capitalization is $134.94B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRA’s FA Score shows that 1 FA rating(s) are green whileSYK’s FA Score has 3 green FA rating(s).

  • BMRA’s FA Score: 1 green, 4 red.
  • SYK’s FA Score: 3 green, 2 red.
According to our system of comparison, SYK is a better buy in the long-term than BMRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRA’s TA Score shows that 5 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).

  • BMRA’s TA Score: 5 bullish, 3 bearish.
  • SYK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BMRA is a better buy in the short-term than SYK.

Price Growth

BMRA (@Medical Specialties) experienced а +2.47% price change this week, while SYK (@Medical Specialties) price change was -0.68% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.00%. For the same industry, the average monthly price growth was +1.71%, and the average quarterly price growth was +1.72%.

Reported Earning Dates

SYK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+1.00% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($135B) has a higher market cap than BMRA($14M). BMRA YTD gains are higher at: 38.287 vs. SYK (5.921). SYK has higher annual earnings (EBITDA): 4.93B vs. BMRA (-5.97M). SYK has more cash in the bank: 3.05B vs. BMRA (7.13M). BMRA has less debt than SYK: BMRA (937K) vs SYK (13B). SYK has higher revenues than BMRA: SYK (20.5B) vs BMRA (5.5M).
BMRASYKBMRA / SYK
Capitalization14M135B0%
EBITDA-5.97M4.93B-0%
Gain YTD38.2875.921647%
P/E RatioN/A42.99-
Revenue5.5M20.5B0%
Total Cash7.13M3.05B0%
Total Debt937K13B0%
FUNDAMENTALS RATINGS
BMRA vs SYK: Fundamental Ratings
BMRA
SYK
OUTLOOK RATING
1..100
199
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
10014
SMR RATING
1..100
9856
PRICE GROWTH RATING
1..100
6153
P/E GROWTH RATING
1..100
10022
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (22) in the Medical Specialties industry is in the same range as BMRA (33). This means that SYK’s stock grew similarly to BMRA’s over the last 12 months.

SYK's Profit vs Risk Rating (14) in the Medical Specialties industry is significantly better than the same rating for BMRA (100). This means that SYK’s stock grew significantly faster than BMRA’s over the last 12 months.

SYK's SMR Rating (56) in the Medical Specialties industry is somewhat better than the same rating for BMRA (98). This means that SYK’s stock grew somewhat faster than BMRA’s over the last 12 months.

SYK's Price Growth Rating (53) in the Medical Specialties industry is in the same range as BMRA (61). This means that SYK’s stock grew similarly to BMRA’s over the last 12 months.

SYK's P/E Growth Rating (22) in the Medical Specialties industry is significantly better than the same rating for BMRA (100). This means that SYK’s stock grew significantly faster than BMRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRASYK
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
55%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
53%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
43%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
49%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
46%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 26 days ago
56%
Declines
ODDS (%)
Bearish Trend 23 days ago
84%
Bearish Trend 1 day ago
51%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
BMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GBERY79.671.47
+1.88%
Geberit AG
BRRLY10.840.20
+1.84%
Barry Callebaut AG
BAYRY8.030.08
+1.01%
Bayer A.G.
AWLIF0.11N/A
-2.75%
AMERIWEST LITHIUM INC
ELRRF0.92-0.05
-5.14%
Eloro Resources Ltd.

BMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRA has been loosely correlated with ZIMV. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRA jumps, then ZIMV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRA
1D Price
Change %
BMRA100%
-3.21%
ZIMV - BMRA
39%
Loosely correlated
-2.62%
LFWD - BMRA
32%
Poorly correlated
-5.00%
SENS - BMRA
27%
Poorly correlated
-0.46%
CALZF - BMRA
26%
Poorly correlated
N/A
SYK - BMRA
24%
Poorly correlated
-0.15%
More

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been closely correlated with ISRG. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYK jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
-0.15%
ISRG - SYK
66%
Closely correlated
-1.80%
MMSI - SYK
56%
Loosely correlated
-0.87%
A - SYK
56%
Loosely correlated
-0.68%
STE - SYK
55%
Loosely correlated
+0.69%
MDT - SYK
53%
Loosely correlated
+0.49%
More